353 related articles for article (PubMed ID: 24379567)
1. Colorectal cancer: current imaging methods and future perspectives for the diagnosis, staging and therapeutic response evaluation.
Kekelidze M; D'Errico L; Pansini M; Tyndall A; Hohmann J
World J Gastroenterol; 2013 Dec; 19(46):8502-14. PubMed ID: 24379567
[TBL] [Abstract][Full Text] [Related]
2. Preoperative evaluation of colorectal cancer using CT colonography, MRI, and PET/CT.
Kijima S; Sasaki T; Nagata K; Utano K; Lefor AT; Sugimoto H
World J Gastroenterol; 2014 Dec; 20(45):16964-75. PubMed ID: 25493009
[TBL] [Abstract][Full Text] [Related]
3. [Technical novelties, latest diagnostic options in the MRI and CT diagnostics of colorectal cancer].
Jederán É; Gõdény M
Magy Onkol; 2015 Sep; 59(3):184-92. PubMed ID: 26339907
[TBL] [Abstract][Full Text] [Related]
4. The accuracy of computed tomography in the pretreatment staging of colorectal cancer.
Tan YN; Li XF; Li JJ; Song YM; Jiang B; Yang J; Yuan Y
Hepatogastroenterology; 2014; 61(133):1207-12. PubMed ID: 25436284
[TBL] [Abstract][Full Text] [Related]
5. Controversies in the management of colorectal liver metastases: role of PET and PET/CT.
Wiering B; Vogel WV; Ruers TJ; Oyen WJ
Dig Surg; 2008; 25(6):413-20. PubMed ID: 19212113
[TBL] [Abstract][Full Text] [Related]
6. Impact of Fluorine-18 2-Fluoro-2-Deoxy-D-Glucose Uptake on Preoperative Positron Emission Tomography/Computed Tomography in the Lymph Nodes of Patients with Primary Colorectal Cancer.
Sasaki K; Kawasaki H; Sato M; Koyama K; Yoshimi F; Nagai H
Dig Surg; 2017; 34(1):60-67. PubMed ID: 27454870
[TBL] [Abstract][Full Text] [Related]
7. Virtual gastrointestinal colonoscopy in combination with large bowel endoscopy: clinical application.
He Q; Rao T; Guan YS
World J Gastroenterol; 2014 Oct; 20(38):13820-32. PubMed ID: 25320519
[TBL] [Abstract][Full Text] [Related]
8. Colonography by CT, MRI and PET/CT combined with conventional colonoscopy in colorectal cancer screening and staging.
Sun L; Wu H; Guan YS
World J Gastroenterol; 2008 Feb; 14(6):853-63. PubMed ID: 18240342
[TBL] [Abstract][Full Text] [Related]
9. PET/CT: will it change the way that we use CT in cancer imaging?
Hicks RJ; Ware RE; Lau EW
Cancer Imaging; 2006 Oct; 6(Spec No A):S52-62. PubMed ID: 17114079
[TBL] [Abstract][Full Text] [Related]
10. Imaging modalities for the staging of patients with colorectal cancer.
Bipat S; Niekel MC; Comans EF; Nio CY; Bemelman WA; Verhoef C; Stoker J
Neth J Med; 2012 Jan; 70(1):26-34. PubMed ID: 22271811
[TBL] [Abstract][Full Text] [Related]
11. Optimizing the role of FDG PET-CT for potentially operable metastatic colorectal cancer.
Culverwell AD; Chowdhury FU; Scarsbrook AF
Abdom Imaging; 2012 Dec; 37(6):1021-31. PubMed ID: 22371087
[TBL] [Abstract][Full Text] [Related]
12. Diagnostic accuracy of CE-CT, MRI and FDG PET/CT for detecting colorectal cancer liver metastases in patients considered eligible for hepatic resection and/or local ablation.
Sivesgaard K; Larsen LP; Sørensen M; Kramer S; Schlander S; Amanavicius N; Bharadwaz A; Tønner Nielsen D; Viborg Mortensen F; Morre Pedersen E
Eur Radiol; 2018 Nov; 28(11):4735-4747. PubMed ID: 29736846
[TBL] [Abstract][Full Text] [Related]
13. More advantages in detecting bone and soft tissue metastases from prostate cancer using
Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
[TBL] [Abstract][Full Text] [Related]
14. Liver metastases from colorectal cancer: imaging with superparamagnetic iron oxide (SPIO)-enhanced MR imaging, computed tomography and positron emission tomography.
Rappeport ED; Loft A
Abdom Imaging; 2007; 32(5):624-34. PubMed ID: 17710359
[TBL] [Abstract][Full Text] [Related]
15. Imaging of colorectal cancer liver metastases using contrast-enhanced US, multidetector CT, MRI, and FDG PET/CT: a meta-analysis.
Tsili AC; Alexiou G; Naka C; Argyropoulou MI
Acta Radiol; 2021 Mar; 62(3):302-312. PubMed ID: 32506935
[TBL] [Abstract][Full Text] [Related]
16. Prospective study on diagnostic and prognostic significance of postoperative FDG PET/CT in recurrent colorectal carcinoma patients: comparison with MRI and tumor markers.
Odalovic S; Stojiljkovic M; Sobic-Saranovic D; Pandurevic S; Brajkovic L; Milosevic I; Grozdic-Milojevic I; Artiko V
Neoplasma; 2017; 64(6):954-961. PubMed ID: 28895416
[TBL] [Abstract][Full Text] [Related]
17. [18F]FDG PET/CT imaging of colorectal cancer: a pictorial review.
Chowdhury FU; Shah N; Scarsbrook AF; Bradley KM
Postgrad Med J; 2010 Mar; 86(1013):174-82. PubMed ID: 20237012
[TBL] [Abstract][Full Text] [Related]
18. Whole-body PET/CT-colonography: a possible new concept for colorectal cancer staging.
Kinner S; Antoch G; Bockisch A; Veit-Haibach P
Abdom Imaging; 2007; 32(5):606-12. PubMed ID: 17387540
[TBL] [Abstract][Full Text] [Related]
19. Update on colorectal cancer imaging.
Gollub MJ; Schwartz LH; Akhurst T
Radiol Clin North Am; 2007 Jan; 45(1):85-118. PubMed ID: 17157625
[TBL] [Abstract][Full Text] [Related]
20. Fluoro-2-deoxy-d-glucose positron emission tomography/computed tomography for the detection of proximal synchronous lesions in patients with obstructive colorectal cancer.
Kim WS; Lee HS; Lee JM; Kwak MS; Hwang SW; Park SH; Yang DH; Kim KJ; Myung SJ; Yang SK; Byeon JS
J Gastroenterol Hepatol; 2017 Feb; 32(2):401-408. PubMed ID: 27418280
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
